Showing results (61-70 of 264) with videos related to

Sort By:
Pageof 27
European Journal of Cancer (Oxford, England : 1990)|May 30, 2006
Prostate-specific antigen (PSA) alone is not an appropriate surrogate marker of long-term therapeutic benefit in prostate cancer trialsLaurence Collette, Tomasz Burzykowski, Fritz H Schröder
Journal of the National Cancer Institute|March 7, 2019
Cumulative Toxicity in Targeted Therapies: What to Expect at the Recommended Phase II DoseMaria-Athina Altzerinakou, Laurence Collette, Xavier Paoletti
European Urology|June 10, 2011
Bowel function remains subjectively unchanged after ileal resection for construction of continent ileal reservoirsBerry Fung, Thomas M Kessler, Katharina Haeni, et al.
The Journal of Urology|May 16, 2006
Ultrasound assessment of detrusor thickness in men-can it predict bladder outlet obstruction and replace pressure flow study?Thomas M Kessler, Rolf Gerber, Fiona C Burkhard, et al.
European Urology|June 2, 2009
Complications following radical cystectomy for bladder cancer in the elderlyMichael Froehner, Maurizio A Brausi, Harry W Herr, et al.
The Journal of Urology|June 7, 2006
Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growthDaniel Peternac, Irena Klima, Marco G Cecchini, et al.
European Urology|October 12, 2004
Ileal orthotopic bladder substitute combined with an afferent tubular segment: long-term upper urinary tract changes and voiding patternPetros Perimenis, Fiona C Burkhard, Thomas M Kessler, et al.
The Journal of Urology|October 24, 2002
Is ileal orthotopic bladder substitution with an afferent tubular segment detrimental to the upper urinary tract in the long term?Harriet C Thoeny, Martin J Sonnenschein, Stephan Madersbacher, et al.
European Radiology|February 18, 2004
Caveats when interpreting intravenous urograms following ileal orthotopic bladder substitutionHarriet C Thoeny, Urs E Studer, Stephan Madersbacher, et al.
Pageof 27